Inhibitor of gastrointestinal lipase used in attempts at weight reduction.Given perorally in a dose of 360 mg/d .Metabolized in the gastrointestinal wall, producing two metabolites. Only insignificant absorbtion, plasma concentration < 10 ng/mL.
IPNet drug reports
Uneventful use reported in 2 patients with acute porphyria.
Similar drugs
Explore alternative drugs in similar therapeutic classes
A08A /
A08AB or
go back.